Annual CFF
$67.87 M
+$24.22 M+55.48%
December 31, 2024
Summary
- As of February 23, 2025, OM annual cash flow from financing activities is $67.87 million, with the most recent change of +$24.22 million (+55.48%) on December 31, 2024.
- During the last 3 years, OM annual CFF has fallen by -$92.28 million (-57.62%).
- OM annual CFF is now -82.40% below its all-time high of $385.68 million, reached on December 31, 2020.
Performance
OM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
December 31, 2024
Summary
- OM quarterly cash flow from financing activities is not available.
Performance
OM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
December 31, 2024
Summary
- OM TTM cash flow from financing activities is not available.
Performance
OM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
OM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.5% | - | - |
| 3 y3 years | -57.6% | - | - |
| 5 y5 years | +10000.0% | - | - |
OM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.6% | +55.5% | ||||
| 5 y | 5-year | -82.4% | >+9999.0% | ||||
| alltime | all time | -82.4% | >+9999.0% |
Outset Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $67.87 M(+55.5%) | - | - |
| Sep 2024 | - | $121.00 K(+57.1%) | $102.04 M(-3.8%) |
| Jun 2024 | - | $77.00 K(-99.9%) | $106.02 M(-0.9%) |
| Mar 2024 | - | $68.61 M(+106.5%) | $106.98 M(+145.1%) |
| Dec 2023 | $43.65 M(-40.1%) | $33.23 M(+709.9%) | $43.65 M(-42.6%) |
| Sep 2023 | - | $4.10 M(+293.4%) | $76.02 M(+2.1%) |
| Jun 2023 | - | $1.04 M(-80.2%) | $74.45 M(+0.0%) |
| Mar 2023 | - | $5.28 M(-92.0%) | $74.45 M(+2.1%) |
| Dec 2022 | $72.90 M | $65.60 M(+2489.8%) | $72.90 M(+785.5%) |
| Sep 2022 | - | $2.53 M(+143.1%) | $8.23 M(-30.7%) |
| Jun 2022 | - | $1.04 M(-72.0%) | $11.89 M(-92.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.72 M(+298.6%) | $161.65 M(+0.9%) |
| Dec 2021 | $160.15 M(-58.5%) | $934.00 K(-84.9%) | $160.15 M(+1.1%) |
| Sep 2021 | - | $6.19 M(-95.9%) | $158.34 M(-61.6%) |
| Jun 2021 | - | $150.81 M(+6699.3%) | $411.91 M(+57.7%) |
| Mar 2021 | - | $2.22 M(-354.1%) | $261.13 M(-32.3%) |
| Dec 2020 | $385.68 M(>+9900.0%) | -$873.00 K(-100.3%) | $385.68 M(-0.2%) |
| Sep 2020 | - | $259.76 M(>+9900.0%) | $386.56 M(+204.9%) |
| Jun 2020 | - | $27.00 K(-100.0%) | $126.80 M(+0.0%) |
| Mar 2020 | - | $126.77 M | $126.77 M |
| Dec 2019 | $249.00 K(-99.8%) | - | - |
| Dec 2018 | $134.87 M | - | - |
FAQ
- What is Outset Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Outset Medical?
- What is Outset Medical annual CFF year-on-year change?
- What is the all time high quarterly CFF for Outset Medical?
- What is the all time high TTM CFF for Outset Medical?
What is Outset Medical annual cash flow from financing activities?
The current annual CFF of OM is $67.87 M
What is the all time high annual CFF for Outset Medical?
Outset Medical all-time high annual cash flow from financing activities is $385.68 M
What is Outset Medical annual CFF year-on-year change?
Over the past year, OM annual cash flow from financing activities has changed by +$24.22 M (+55.48%)
What is the all time high quarterly CFF for Outset Medical?
Outset Medical all-time high quarterly cash flow from financing activities is $259.76 M
What is the all time high TTM CFF for Outset Medical?
Outset Medical all-time high TTM cash flow from financing activities is $411.91 M